Standout Papers

Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer 2015 2026 2018 2022 440
  1. Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer (2015)
    Sara M. Tolaney, William T. Barry et al. New England Journal of Medicine

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 54 standout
Sub-graph 1 of 19

Citing Papers

Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
2025 Standout
Quantifying the impact of misinformation and vaccine-skeptical content on Facebook
2024 StandoutScience
1 intermediate paper

Works of Hao Guo being referenced

Using Text Mining to Compare Online Pro- and Anti-Vaccine Headlines: Word Usage, Sentiments, and Online Popularity
2017
Adjuvant Paclitaxel and Trastuzumab for Node-Negative, HER2-Positive Breast Cancer
2015 Standout

Author Peers

Author Last Decade Papers Cites
Hao Guo 871 292 483 61 1.4k
Elisa Agostinetto 956 416 455 84 1.4k
Paula Silverman 887 303 395 60 1.5k
Maria Theodoulou 1018 375 358 41 1.5k
César A. Rodríguez 601 200 359 73 1.3k
Ching‐Wei Chang 560 362 267 60 1.4k
Aranzazu Fernández-Martínez 683 264 553 44 1.4k
Andrew Brown 584 295 385 50 1.6k
Uma Krishnamurti 645 190 355 55 1.3k
Peng Yuan 395 143 336 64 1.2k
Juliane Hannemann 662 250 774 58 1.6k

All Works

Loading papers...

Rankless by CCL
2026